270 related articles for article (PubMed ID: 24342638)
1. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
2. Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
Micaëlo M; Brossier F; Bréchot N; Luyt CE; Lu Q; Monsel A; Jarlier V; Aubry A
Med Mal Infect; 2018 Aug; 48(5):365-371. PubMed ID: 29628176
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence.
Crandon JL; Luyt CE; Aubry A; Chastre J; Nicolau DP
J Antimicrob Chemother; 2016 Sep; 71(9):2534-7. PubMed ID: 27272723
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
[TBL] [Abstract][Full Text] [Related]
6. Comparative review of the carbapenems.
Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
[TBL] [Abstract][Full Text] [Related]
7. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
Goyal K; Gautam V; Ray P
Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.
Kollef MH; Chastre J; Clavel M; Restrepo MI; Michiels B; Kaniga K; Cirillo I; Kimko H; Redman R
Crit Care; 2012 Nov; 16(6):R218. PubMed ID: 23148736
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia.
Liu WD; Shih MC; Chuang YC; Wang JT; Sheng WH
J Microbiol Immunol Infect; 2019 Oct; 52(5):788-795. PubMed ID: 31155463
[TBL] [Abstract][Full Text] [Related]
10. Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
Kollef MH; Nathwani D; Merchant S; Gast C; Quintana A; Ketter N
Crit Care; 2010; 14(3):R84. PubMed ID: 20459721
[TBL] [Abstract][Full Text] [Related]
11. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
Rios FG; Luna CM; Maskin B; Saenz Valiente A; Lloria M; Gando S; Sosa C; Baquero S; Llerena C; Petrati C; Apezteguia C
Eur Respir J; 2007 Aug; 30(2):307-13. PubMed ID: 17504791
[TBL] [Abstract][Full Text] [Related]
12. Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
Merchant S; Gast C; Nathwani D; Lee M; Quintana A; Ketter N; Friedland I; Ingham M
Clin Ther; 2008 Apr; 30(4):717-33. PubMed ID: 18498921
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Pillar CM; Torres MK; Brown NP; Shah D; Sahm DF
Antimicrob Agents Chemother; 2008 Dec; 52(12):4388-99. PubMed ID: 18779357
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
[TBL] [Abstract][Full Text] [Related]
15. [Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
Gimeno C; Cantón R; García A; Gobernado M;
Rev Esp Quimioter; 2010 Sep; 23(3):144-52. PubMed ID: 20844845
[TBL] [Abstract][Full Text] [Related]
16. Prospective monitoring of carbapenem use and pseudomonal resistance across pediatric institutions.
Miyairi I; Shoji K; Kinoshita N; Saitoh J; Sugahara Y; Watanabe Y; Komura M; Kasai M; Horikoshi Y; Shinjoh M; Igarashi T;
Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1042-1047. PubMed ID: 32484118
[TBL] [Abstract][Full Text] [Related]
17. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
Hilliard JJ; Melton JL; Hall L; Abbanat D; Fernandez J; Ward CK; Bunting RA; Barron A; Lynch AS; Flamm RK
Antimicrob Agents Chemother; 2011 Feb; 55(2):836-44. PubMed ID: 21135187
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]